SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is facing intense selling pressure as it dips below the psychological $1 mark, fueling heated debates between investors accumulating the asset at lower prices and skeptics who view the project as a failing cautionary tale. The conversation is dominated by frustration over the lack of anticipated regulatory progress and growing concern regarding the impact of ongoing token dilution on future price performance.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as investors bet on a potential short squeeze fueled by high short interest and anticipation of upcoming clinical catalysts for its TIL therapy. The community is actively discussing the company's strong institutional backing and growth potential in lung cancer, while maintaining high conviction in the stock's long-term value despite ongoing market volatility.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently trending as investors weigh significant project milestones, such as obtaining construction permits for its Texas data center campus, against concerns regarding quarterly earnings and cash burn. Community discussion is sharply divided between bulls focused on the company's de-risking progress and off-grid power strategy, and skeptics emphasizing a lack of finalized tenant contracts and the company's profitability challenges.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is currently trending as investors focus on its involvement in the sovereign AI infrastructure market and the potential for an upcoming earnings catalyst. While the community debates the impact of potential dilution and recent management communication, many are closely watching for updates on key revenue milestones and contract execution in the SE Asia region.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors monitor the company's recent uplisting to the NYSE and the broader industry's ongoing transition to Schedule III status. The community is actively debating the impact of the company's share buyback program and the potential for increased institutional participation as regulatory hurdles for U.S. cannabis operators continue to evolve.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap is experiencing intense community focus as traders rally behind the 'UNIfication' governance proposal, which aims to activate a fee switch and trigger a massive token burn. This potential shift toward a deflationary model is driving optimism, though the market remains volatile as investors closely watch for the final governance vote.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle Corp is trending as investors weigh strong earnings momentum and lithium supply chain recovery against recent price volatility, with community sentiment focused on the stock's resilience ahead of upcoming inflation data and potential long-term energy storage growth. Discussions remain heavily polarized between long-term bulls highlighting lithium demand and technical traders closely monitoring key support levels to determine if the stock is staging a healthy pullback or entering a deeper correction.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is trending as investors monitor the upcoming Phase 3 readouts for DURAVYU, with community discussion centered on its competitive positioning against other TKI-based retinal therapies. Analysts remain focused on institutional accumulation and the potential for a significant re-rating of the stock as clinical milestones approach.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as investors debate the impact of share dilution and the company's aggressive Bitcoin treasury strategy amidst a period of price volatility. The community remains deeply divided, with bulls pointing to institutional accumulation and potential index inclusion, while bears highlight concerns over the company's reliance on capital raising to fund Bitcoin purchases and dividends.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

Lightpath Technologies is trending as investors focus on its critical role in the defense and C-UAS supply chain, particularly through its BlackDiamond technology which serves as a strategic substitute for restricted Germanium. The community is actively discussing the stock's potential for a significant re-rating as it pivots to a Western-aligned manufacturing footprint and secures ongoing interest from major defense contractors and government initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9% - Here's What Happened

ABVC BioPharma (NASDAQ:ABVC) Shares Down 4.9% - Here's What Happened...

ABVC BioPharma (NASDAQ:ABVC) Trading 1.6% Higher - What's Next?

ABVC BioPharma (NASDAQ:ABVC) Stock Price Up 1.6% - Time to Buy...

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

ABVC BioPharma Inc

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.8999
Prev Close	$0.9594
Open	$0.95
Dividend Yield	0.00%
50-Day Moving Average	$1.30
Beta	0.94
Avg. Volume	158,340.14
PE Ratio	-3.33

52-Week High	$3.40
52-Week Low	$0.8801
Market Capitalization	$25.57M
EPS (Annual)	-$0.3933
Price to Book	2.40
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info